BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 19837258)

  • 1. A comprehensive perspective on patient adherence to topical glaucoma therapy.
    Tsai JC
    Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-centered communication to assess and enhance patient adherence to glaucoma medication.
    Hahn SR
    Ophthalmology; 2009 Nov; 116(11 Suppl):S37-42. PubMed ID: 19837259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinician's guide to the assessment and management of nonadherence in glaucoma.
    Budenz DL
    Ophthalmology; 2009 Nov; 116(11 Suppl):S43-7. PubMed ID: 19837260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS; Okeke CO; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Quigley HA
    Ophthalmology; 2009 Jun; 116(6):1097-105. PubMed ID: 19376591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication adherence in glaucoma: approaches for optimizing patient compliance.
    Tsai JC
    Curr Opin Ophthalmol; 2006 Apr; 17(2):190-5. PubMed ID: 16552255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
    Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
    Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of practice patterns for the care of open-angle glaucoma compared with claims data: the Glaucoma Adherence and Persistency Study.
    Quigley HA; Friedman DS; Hahn SR
    Ophthalmology; 2007 Sep; 114(9):1599-606. PubMed ID: 17572498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
    Rees G; Leong O; Crowston JG; Lamoureux EL
    Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction: new insights on enhancing adherence to topical glaucoma medications.
    Friedman DS
    Ophthalmology; 2009 Nov; 116(11 Suppl):S29. PubMed ID: 19837257
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of glaucoma medications: state of the science and directions for observational research.
    Lu VH; Goldberg I; Lu CY
    Am J Ophthalmol; 2010 Oct; 150(4):569-574.e9. PubMed ID: 20678750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy?
    Robin AL; Covert D
    Ophthalmology; 2005 May; 112(5):863-8. PubMed ID: 15878067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).
    Friedman DS; Quigley HA; Gelb L; Tan J; Margolis J; Shah SN; Kim EE; Zimmerman T; Hahn SR
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5052-7. PubMed ID: 17962457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data.
    Dasgupta S; Oates V; Bookhart BK; Vaziri B; Schwartz GF; Mozaffari E
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S255-61. PubMed ID: 12188168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health literacy and adherence to glaucoma therapy.
    Muir KW; Santiago-Turla C; Stinnett SS; Herndon LW; Allingham RR; Challa P; Lee PP
    Am J Ophthalmol; 2006 Aug; 142(2):223-6. PubMed ID: 16876500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obstacles to medication compliance for patients with glaucoma].
    Kowal M; Choragiewicz T; Mietlicka K; WyszyƄska A; Zarnowski T
    Klin Oczna; 2008; 110(10-12):347-51. PubMed ID: 19195163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence: a review of the literature and implications for clinical practice.
    Julius RJ; Novitsky MA; Dubin WR
    J Psychiatr Pract; 2009 Jan; 15(1):34-44. PubMed ID: 19182563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV; Chang DS; Frazier T; Plyler R; Friedman DS
    JAMA Ophthalmol; 2014 Jul; 132(7):838-44. PubMed ID: 24830878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients.
    Kharod BV; Johnson PB; Nesti HA; Rhee DJ
    J Glaucoma; 2006 Jun; 15(3):244-7. PubMed ID: 16778648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study.
    Gelb L; Friedman DS; Quigley HA; Lyon DW; Tan J; Kim EE; Zimmerman TJ; Hahn SR
    J Glaucoma; 2008 Dec; 17(8):690-8. PubMed ID: 19092468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.